Patrick Amstutz
Found 5 people in Virginia, Michigan, Washington and other states
-
+99
-
+98
-
+97
-
-
+95
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Sponsored by SpokeoPaid Service
Patrick Amstutz
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
patrick_a.stutz - @patrick_a.stutz
1 follower
patrice Amstutz - @patriceamstutz
Joie
4 followers
pampam - @patriceamstutz7
4 followers
Patrick Amstutz - @patrickamstutz479
1 subscriber
Patrick Amstutz - @patrickamstutz3438
1 subscriber
Patrick Amstutz
Life Science Cares Switzerland
Patrick Amstutz
Director Transaction Services
Patrick Amstutz
Médecins Sans Frontières (MSF)
Patrick Amstutz
UBS Immo Partner Zentralschweiz
Patrick Amstutz
Assistent Expansion/Ladenbau
Patrick Amstutz
Gebietsmanager Telecom bei ewz
Patrick Amstutz
Marketing Kommunikation bei IP-SUISSE
Patrick Amstutz
Mitarbeiter bei ZGKB
Patrick Amstutz
Sponsored by PeopleLookerPaid Service
Search for Patrick Amstutz's city and state history
Search address historyWebsites owned by Patrick Amstutz
fclerchenfeld3.com
Registered on August 13, 2010
FDA rejects approval of AbbVie, Molecular Partners' abicipar pegol for AMD
FirstWord Pharma - Sat, 16 Aug 2025
Molecular Partners to cut workforce by a quarter
ETHRWorld.com - Tue, 10 Jun 2025
Molecular Partners Reveals Major Reset: 40 Jobs Cut as Biotech Extends Cash Runway by Extra Year
Stock Titan - Tue, 10 Jun 2025
Molecular Partners cuts quarter of staff to prioritise two clinical-stage assets
FirstWord Pharma - Tue, 10 Jun 2025
Novartis-Molecular Partners COVID drug could be approved in weeks
Reuters - Mon, 10 Jan 2022
Molecular Partners reports financial results and highlights recent clinical pipeline progress for H1 2025
The Manila Times - Tue, 26 Aug 2025
Molecular Partners names Regeneron cancer leader as CSO in reshuffle of leadership team
Fierce Biotech - Thu, 21 Jun 2018
Molecular Partners Reports Financial Results and Highlights from Q1 2025
The Manila Times - Fri, 16 May 2025
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Patrick Amstutz - @novaverso
23 photos - 0 followers
moi moi - @usermame
0 photos - 0 followers
Patrick Amstutz - @patrick99_amstutz
0 followers
Patrick Amstutz - @patrickamstutz
3 followers
Patrick Amstutz - @patrick1amstutz
0 followers
Patrick Amstutz - @amstutz90
0 followers
Patrick Amstutz - @amstutz0955
0 followers
Patrick Amstutz - @amstutpa
0 followers
Patrick Amstutz - @amstutz3611
0 followers
Patrick Amstutz - @patrick8447amstutz
0 followers
Patrick Amstutz - @patrickamstutz2
0 followers
Patrick Amstutz
www.xing.com
About Us - Molecular Partners
Patrick Amstutz, Ph.D. · Chief Executive Officer and Member of the Management Board, Member of the Board of Directors ; Alexander ZürcherChief Operating Officer ...
Patrick Amstutz – CEO, Molecular Partners - PharmaBoardroom
Patrick Amstutz co-founded Molecular Partners 20 years ago with a vision to revolutionize medicine through protein engineering.
Patrick Amstutz - MLLCF | Molecular Partners AG - Wall Street Journal
Patrick Amstutz is the founder of Molecular Partners AG, where the founding year is 2004, and holds the title of Chief Executive Officer & Director since ...
Swiss Biotech Association elects Molecular Partners' CEO Patrick ...
Molecular Partners' Chief Executive Officer Patrick Amstutz, Ph.D., has been elected President of the Swiss Biotech Association Board of Directors.
Molecular Partners' CEO and Swiss Biotech Association president ...
Molecular Partners' CEO and Swiss Biotech Association president Patrick Amstutz shares his take on biotech and previews what to expect from his US listed ...
Patrick Amstutz, Molecular Partners AG: Profile and Biography
Patrick Amstutz is CEO/Co-Founder at Molecular Partners AG. See Patrick Amstutz's compensation, career history, education, & memberships.
Team - Swiss Biotech Association
Dr. Patrick Amstutz is acting Chief Executive Officer of Molecular Partners AG in Schlieren. He co-founded Molecular Partners and has been a member of the ...